The CEOs from Roche and Sanofi joined Novartis in raising the presence of non-U.S. companies on the list this year. [© Tijana - Fotolia.com]
#8. Joseph Jimenez
Company: Novartis
Full title: CEO
2012 Compensation: $14,196,551 (CHF: 13,228,188)1
2011 Compensation: $16,874,192 (CHF: 15,722,386)1
% Change: -15.9%
Position on 2012 List: #6
#7. John C. Lechleiter, Ph.D.
Company: Eli Lilly
Full title: Chairman of the Board, President, and CEO
2012 Compensation: $14,620,633
2011 Compensation: $16,370,094
% Change: -10.7%
Position on 2012 List: #5
#6. John C. Martin
Company: Gilead Sciences
Full title: Chairman of the Board and CEO
2012 Compensation: $15,257,272
2011 Compensation: $15,615,645
% Change: -2.3%
Position on 2012 List: #7
#5. Kenneth C. Frazier
Company: Merck & Co.
Full title: Chairman of the Board, President, and CEO
2012 Compensation: $15,459,607
2011 Compensation: $13,347,652
% Change: 15.8%
Position on 2012 List: #10
#4. Lamberto Andreotti
Company: Bristol-Myers Squibb
Full title: CEO
2012 Compensation: $17,201,980
2011 Compensation: $14,911,947
% Change: 15.4%
Position on 2012 List: #8
#3. Ian Read
Company: Pfizer
Full title: Chairman of the Board and CEO
2012 Compensation: $25,634,136
2011 Compensation: $25,013,348
% Change: 2.5%
Position on 2012 List: #2
#2. William C. Weldon
Company: Johnson & Johnson
Full title: Chairman of the Board until December 28, 2012; CEO until April 26, 2012
2012 Compensation: $29,838,259
2011 Compensation: $26,797,939
% Change: 11.3%
Position on 2012 List: #1
#1. Leonard S. Schleifer, M.D., Ph.D.
Company: Regeneron
Full title: President and CEO
2012 Compensation: $30,047,0972
2011 Compensation: $10,562,661
% Change: 184.5%
Position on 2012 List: Not ranked